Health news
Health news top Health news

   Login  |  Register    
Health News Make AMN Your Home PageDiscussion BoardsAdvanced Search ToolMedical RSS/XML News FeedHealth news
  You are here : Health.am > Health Centers > Cancer Health CenterBreast Cancer news

Obesity, estrogen breakdown tied to breast cancer

Breast Cancer newsFeb 24, 2006

Among women not using hormone therapy, obesity and the byproducts of estrogen breakdown appear to raise the risk of breast cancer, according to findings published in the International Journal of Cancer.

“Hormone therapy and body mass index (BMI) have been associated with postmenopausal breast cancer,” Dr. Francesmary Modugno, of the University of Pittsburgh, and colleagues write. “Because estrogen metabolism may affect breast cancer risk and can be altered by weight and hormone therapy, it might play a role in the hormone therapy-BMI-breast cancer associations.”

BMI is the ratio of body weight and height, and a score of 30 or higher is considered obese.

The researchers analyzed data from subjects enrolled in the Observational Study of the Women’s Health Initiative to examine relationships among obesity, hormone therapy, estrogen metabolism and breast cancer. They compared levels of two estrogen metabolic chemicals, 2-OHE1 and 16-alpha-OHE1, in 200 women who developed breast cancer and in 200 who did not.

In women who used hormone therapy, there was a modest but significant increase in 16-alpha-OHE1 and significantly higher 2-OHE1 levels in both groups. For these subjects, there was no association among BMI, estrogen metabolism and breast cancer risk.

For women who did not use hormone therapy, however, “greater BMI and higher 16-alpha-OHE1 were individually and jointly associated with increased cancer risk,” the investigators found. Compared with women with low BMI and low estrogen metabolite levels, those with a high BMI and high 16-alpha-OHE1 were 3.5-times more likely to develop breast cancer.

Estrogen metabolism is affected by both BMI and hormone therapy, the team concludes, “potentially explaining the interaction between BMI and hormone therapy in relation to breast cancer risk.”

SOURCE: International Journal of Cancer, March 2006.

Provided by ArmMed Media
Revision date: July 9, 2011
Last revised: by David A. Scott, M.D.

Email this to a friend Bookmark this! Printable Version

RELATED STORIES:


 Comments [ + Post Your Own

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]




We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.

All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

Please enter the word you see in the image below:


   [advanced search]   
Interactive Quiz:
1. An infant who sits with only minimal support, attempts to attain a toy beyond reach, and rolls over from the supine to the prone position, but does not have a pincer grasp, is at a developmental level of
2 months
4 months
6 months
9 months
1 year



Health Centers

Health Centers





Diabetes









Health news
  


Health Encyclopedia

Diseases & Conditions

Drugs & Medications

Health Tools

Health Tools



   Health newsletter

  





   Medical Links



   RSS/XML News Feed



   Feedback






Breast Cancer news from Armenian Medical Network
Add to My AOL
Add to Google Reader or Homepage




What is Levonorgestrel Emergency contraceptive Kit. Levonorgestrel can prevent ovulation and pregnancy after unprotected sex

hit counter